Study of indications for cardiac device implantation and utilisation in Fabry cardiomyopathy.
Ravi VijapurapuTarekegn GeberhiwotAna JovanovicShanat BaigSabrina NordinRebecca KozorFrancisco LeyvaDipak KotechaNigel WheeldonPatrick DeeganRosemary A RuskJames C MoonDerralynn A HughesPeter WoolfsonRichard P SteedsPublished in: Heart (British Cardiac Society) (2019)
Arrhythmias are common in Fabry patients. Those with cardiac devices had high rates of atrial fibrillation requiring anticoagulation and ventricular arrhythmia needing device treatment. These are as high as those in hypertrophic cardiomyopathy, supporting the need for Fabry-specific indications for device implantation.
Keyphrases
- hypertrophic cardiomyopathy
- left ventricular
- atrial fibrillation
- heart failure
- replacement therapy
- catheter ablation
- left atrial
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- peritoneal dialysis
- venous thromboembolism
- prognostic factors
- left atrial appendage
- oral anticoagulants
- patient reported outcomes
- percutaneous coronary intervention
- coronary artery disease
- smoking cessation
- direct oral anticoagulants
- acute coronary syndrome